Current role of dexmedetomidine in clinical anesthesia and intensive care
|
 |
|
Post a Comment
|
|
|
|
|
CONTRIBUTORS:
|
|
|
JOURNAL:
|
Anesth Essays Res,
5(??),
128 -
133.
|
|
|
|
YEAR:
|
2011
|
|
PUB TYPE:
|
Journal Article
|
|
SUBJECT(S):
|
None
|
|
DISCIPLINE:
|
Education
|
|
HTTP:
|
|
|
LANGUAGE:
|
English
|
|
PUB ID:
|
103-502-523
(Last edited on
2012/05/06 01:38:19 GMT-6)
|
|
SPONSOR(S):
|
|
|
ABSTRACT:
Dexmedetomidine is a new generation highly selective α2-adrenergic receptor (α2-AR) agonist that
is associated with sedative and analgesic sparing effects, reduced delirium and agitation, perioperative
sympatholysis, cardiovascular stabilizing effects, and preservation of respiratory function. The aim of
this review is to present the most recent topics regarding the advantages in using dexmedetomidine
in clinical anesthesia and intensive care, while discussing the controversial issues of its harmful effects.
|
|
|
|
STATISTICS
|
|
Click on # to view
|
|
Citations
|
|
0
|
|
References
|
|
0
|
|
Comments
|
|
0
|
|
Quality
|
|
0/0.00
|
|
Interest
|
|
0/0.00
|
|
View(er)s
|
|
2/157
|
|
|
|
|
|
|
| Prev |
Next |
|